Authorization

GT Molecular Ships its Patent-Pending Multiplexed RT-qPCR Test for the Omicron and Delta Coronavirus Variants

FORT COLLINS, Colo., Jan. 27, 2022 /PRNewswire/ -- GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529.
GT Molecular Ships its Patent-Pending Multiplexed RT-qPCR Test for the Omicron and Delta Coronavirus Variants
GT Molecular now shipping its SARS-CoV-2 Omicron and Delta multiplexed RT-qPCR kitsTwo offerings are available for the detection of Omicron (B.1.1.529) and other variants:1. Patent-pending RT-qPCR and digital PCR reagent kits designed specifically for the Omicron, Delta, Delta+ and other variants. One easy-to-use kit with primers, probes & controls and available on multiple PCR platforms.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2022    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
3031